|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
N/A |
| Shares
Out: |
239,210,000 |
| Market
Cap: |
478.42(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $1.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market™ technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane™, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane™ sweetener.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
17,155 |
| Total Buy Value |
$0 |
$0 |
$0 |
$69,135 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
20,999 |
4,403,696 |
| Total Sell Value |
$0 |
$0 |
$19,949 |
$15,923,478 |
| Total People Sold |
0 |
0 |
1 |
6 |
| Total Sell Transactions |
0 |
0 |
1 |
15 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Duyk Geoffrey M |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,566 |
23,398 |
|
- |
|
| Kelsey Nicole |
GENERAL COUNSEL AND SECRETARY |
• – – |
2020-08-01 |
4 |
D |
$4.28 |
$10,358 |
D/D |
(2,420) |
90,781 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2020-07-01 |
4 |
D |
$4.53 |
$282,871 |
D/D |
(62,444) |
567,599 |
|
- |
|
| Kung Frank |
Director |
– • – |
2020-06-05 |
4 |
B |
$3.00 |
$11,067,675 |
I/I |
3,689,225 |
551,884 |
2.1 |
-40% |
|
| Hughes Anthony |
Chief Accounting Officer |
• – – |
2020-06-01 |
4 |
D |
$5.35 |
$34,454 |
D/D |
(6,440) |
42,995 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2020-05-01 |
4 |
D |
$2.49 |
$30,014 |
D/D |
(12,054) |
630,043 |
|
- |
|
| Kelsey Nicole |
General Counsel and Secretary |
• – – |
2020-05-01 |
4 |
D |
$2.49 |
$28,468 |
D/D |
(11,433) |
93,201 |
|
- |
|
| Kieftenbeld Hermanus |
Chief Financial Officer |
• – – |
2020-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
67,500 |
67,500 |
|
- |
|
| Doerr L John |
Director |
– • • |
2020-03-11 |
4 |
OE |
$2.87 |
$15,000,000 |
I/I |
5,226,481 |
58,490,128 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2020-02-19 |
4/A |
S |
$3.41 |
$179,997 |
D/D |
(52,785) |
642,097 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2020-02-19 |
4 |
S |
$3.41 |
$180,304 |
D/D |
(52,875) |
642,097 |
|
-26% |
|
| Doerr L John |
Director |
– • – |
2020-02-19 |
4 |
B |
$3.41 |
$179,997 |
I/I |
52,785 |
53,263,647 |
2.1 |
26% |
|
| Doerr L John |
Director |
– • • |
2020-01-31 |
4 |
B |
$2.87 |
$30,151,221 |
I/I |
10,505,652 |
53,210,862 |
2.25 |
46% |
|
| Doerr L John |
Director |
– • • |
2020-01-31 |
4 |
OE |
$0.15 |
$54,767,092 |
I/I |
19,287,780 |
42,705,210 |
|
- |
|
| Doerr L John |
Director |
– • • |
2020-01-13 |
4 |
OE |
$2.87 |
$13,998,098 |
I/I |
4,877,386 |
23,417,430 |
|
- |
|
| Valiasek Kathleen |
Chief Business Officer |
• – – |
2020-01-01 |
4 |
D |
$3.09 |
$4,688 |
D/D |
(1,517) |
225,006 |
|
- |
|
| Yang Patrick Y |
Director |
– • – |
2019-12-10 |
4 |
S |
$3.10 |
$33,080 |
D/D |
(10,671) |
43,527 |
|
- |
|
| Kung Frank |
Director |
– • – |
2019-11-01 |
4 |
A |
$0.00 |
$0 |
I/I |
667 |
3,600 |
|
- |
|
| Kung Frank |
Director |
– • – |
2019-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(667) |
2,932 |
|
- |
|
| Doerr L John |
Director |
– • • |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
7,798 |
|
- |
|
| Mills Ateven Richard |
Director |
– • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
4,532 |
|
- |
|
| Kung Frank |
Director |
– • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
3,599 |
|
- |
|
| Mccann James F |
Director |
– • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
2,756 |
|
- |
|
| Williams R Neil |
Director |
– • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
7,398 |
|
- |
|
| Duyk Geoffrey M |
Director |
– • – |
2019-10-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,566 |
13,832 |
|
- |
|
402 Records found
|
|
Page 5 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
